The risk factors of portal vein thrombosis in patients with liver cirrhosis.

This study was designed to identify and assess risk factors for portal vein thrombosis (PVT) in patients with cirrhosis. A total of 98 cirrhosis patients with PVT were identified and 101 cirrhosis patients without PVT were chosen as the control group in this retrospective study. Several variables were measured and the two groups PVT and non-PVT were compared statistically. PVT was identified in 98 patients (10%). Significant differences in hematocrit, international normalized ratio, albumin, bilirubin and glucose were determined between the groups (P<0.05). Out of the thrombophilic risk factors in the patients with PVT factor V Leiden was identified in 8.8%, prothrombin gene 6.6% and methylenetetrahydrofolate reductase 2.2%. There was no difference in survival time between groups (P>0.05).

[1]  E. Kouroumalis,et al.  Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges , 2018, Annals of gastroenterology.

[2]  R. Porte,et al.  Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients. , 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[3]  Ashish Kumar,et al.  Review article: portal vein obstruction – epidemiology, pathogenesis, natural history, prognosis and treatment , 2015, Alimentary pharmacology & therapeutics.

[4]  S. Chevret,et al.  Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: Results of a longitudinal study , 2015, Hepatology.

[5]  K. Raja,et al.  Portal vein thrombosis in cirrhosis. , 2014, Journal of clinical and experimental hepatology.

[6]  D. Fan,et al.  Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  X. Qi,et al.  A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics & risk factors , 2014, The Indian journal of medical research.

[8]  D. Fan,et al.  Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis. , 2013, Thrombosis research.

[9]  A. Nicoll.  Surgical risk in patients with cirrhosis , 2012, Journal of gastroenterology and hepatology.

[10]  A. Gasbarrini,et al.  What we should know about portal vein thrombosis in cirrhotic patients: a changing perspective. , 2012, World journal of gastroenterology.

[11]  D. Valla,et al.  Portal vein thrombosis, cirrhosis, and liver transplantation. , 2012, Journal of hepatology.

[12]  R. Goldberg,et al.  Venous thromboembolism in patients with diabetes mellitus. , 2012, The American journal of medicine.

[13]  C. Zhang,et al.  Prevalence of the JAK2V617F mutation in Chinese patients with Budd‐Chiari syndrome and portal vein thrombosis: A prospective study , 2012, Journal of gastroenterology and hepatology.

[14]  T. Wen,et al.  Preoperative predictors of portal vein thrombosis after splenectomy with periesophagogastric devascularization. , 2012, World journal of gastroenterology.

[15]  D. Valla,et al.  Hypercoagulability in cirrhosis: causes and consequences 1 , 2011, Journal of thrombosis and haemostasis : JTH.

[16]  C. Auewarakul,et al.  High Incidence of Hepatitis B Infection-Associated Cirrhosis and Hepatocellular Carcinoma in the Southeast Asian Patients with Portal Vein Thrombosis , 2011, BMC gastroenterology.

[17]  K. Ghosh,et al.  Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis--a concise review. , 2011, Thrombosis research.

[18]  K. Chayama,et al.  Splenectomy in Chronic Hepatic Disorders: Portal Vein Thrombosis and Improvement of Liver Function , 2011, Digestive Surgery.

[19]  R. Merion,et al.  Portal vein thrombosis and liver transplant survival benefit , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[20]  S. Reinert,et al.  Venous thrombosis in patients with chronic liver disease , 2010, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[21]  R. Porte,et al.  The role of platelets in liver inflammation and regeneration. , 2010, Seminars in thrombosis and hemostasis.

[22]  R. Arya,et al.  Haemostasis and thrombosis in liver disease , 2010, British journal of haematology.

[23]  Ning Yang,et al.  Protein C and D‐dimer are related to portal vein thrombosis in patients with liver cirrhosis , 2010, Journal of gastroenterology and hepatology.

[24]  K. Konishi,et al.  Impact of Antithrombin III Concentrates on Portal Vein Thrombosis After Splenectomy in Patients With Liver Cirrhosis and Hypersplenism , 2010, Annals of surgery.

[25]  J. Marrero,et al.  Portal vein thrombosis and survival in patients with cirrhosis , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[26]  O. Dabbagh,et al.  Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. , 2008, Chest.

[27]  A. Gasbarrini,et al.  Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. , 2009, Journal of hepatology.

[28]  R. Schmid,et al.  Correlation of routinely used coagulation parameters and presence of portal vein thrombosis in patients with liver cirrhosis , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[29]  G. Lowe.  Common risk factors for both arterial and venous thrombosis , 2008, British journal of haematology.

[30]  F. Violi,et al.  Portal vein thrombosis in liver cirrhosis , 2008, Internal and emergency medicine.

[31]  D. Valla,et al.  Nonmalignant portal vein thrombosis in adults , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[32]  S. Caldwell,et al.  Coagulopathy Does Not Fully Protect Hospitalized Cirrhosis Patients from Peripheral Venous Thromboembolism , 2006, The American Journal of Gastroenterology.

[33]  M. Björck,et al.  Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. , 2006, World journal of gastroenterology.

[34]  M. Movahed,et al.  The prevalence of pulmonary embolism and pulmonary hypertension in patients with type II diabetes mellitus. , 2005, Chest.

[35]  F. Violi,et al.  Evaluation of D-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis. , 2005, The Journal of laboratory and clinical medicine.

[36]  A. Gader,et al.  Haemostatic abnormalities in liver disease: could some haemostatic tests be useful as liver function tests? , 2005 .

[37]  D. Valla,et al.  Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. , 2005, Journal of hepatology.

[38]  M. Margaglione,et al.  Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. , 2004, Journal of hepatology.

[39]  D. Valla,et al.  Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors , 2000, Hepatology.

[40]  M. Margaglione,et al.  Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis , 2000, Hepatology.

[41]  Y. Bayraktar,et al.  The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis. , 2000, Journal of clinical gastroenterology.

[42]  H. Teufelsbauer,et al.  Hemostasis activation in patients with liver cirrhosis. , 1995, Thrombosis research.

[43]  L. Bolondi,et al.  Value of measurement of mean portal flow velocity by Doppler flowmetry in the diagnosis of portal hypertension. , 1992, Journal of hepatology.